0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query hjresearch global pulmonary arterial hypertension pah medicine industry market research 2018.Your search for "" gave back 1533063 results.
Arterial Thrombosis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2020
Price: USD 2,000.00
Nuclear Factor Erythroid 2 Related Factor 2 - Pipeline Review, H1 2020 Summary Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Arterial Thrombosis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Arterial Thrombosis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
May 2019
Price: USD 2,000.00
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2018 Summary According to the recently published report 'Soluble Guanylate...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Tracleer (bosentan) is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group 1), which...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review, H1 2018 Summary Nuclear...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Soluble guanylyl...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Soluble Guanylate Cyclase - Pipeline Review, H2 2020 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) pipeline Target constitutes close to 29...
Catalog:
Global Markets Direct
November 2020
Price: USD 3,500.00
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Tracleer (bosentan) is a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension (PAH, WHO Group 1), which...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
